Need help? Our team of experienced experts is here for you with full support.
AKA-232
Ertapenem Sodium
Cat. No.
AKA-232
CAS No.
153773-82-1
MF
C22H24N3NaO7S
MW
497.5
Ertapenem sodium is a broad-spectrum long-acting β-lactam with activity against anaerobes.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Data
Description
Storage and Shipping
References
Product Name
Ertapenem Sodium
CAS No.
153773-82-1
MF
C22H24N3NaO7S
MW
497.5
Specification
98%
Research Area
Antibiotic
Description
Ertapenem sodium is a broad-spectrum long-acting β-lactam with activity against anaerobes. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g, 1kg Availability: In stock
Documents
Certificate of Analysis (COA), API specification, Safety Data Sheet (SDS/MSDS), evidence of GMP compliance, Stability data / Stability summary, etc.
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Aldridge KE. Ertapenem (MK-0826), a new carbapenem: comparative in vitro activity against clinically significant anaerobes. Diagnostic Microbiology and Infectious Disease. 2002 Oct;44(2):181-6.
[2]. Gill CJ, et al. In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345). Antimicrobial Agents and Chemotherapy. 1998 Aug;42(8):1996-2001.
[2]. Gill CJ, et al. In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345). Antimicrobial Agents and Chemotherapy. 1998 Aug;42(8):1996-2001.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.